PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS

NIH RePORTER · NIH · N01 · $300,728 · view on reporter.nih.gov ↗

Abstract

Preclinical Toxicology of Large Molecule Drugs Developed for Cancer and Other Indications.

Key facts

NIH application ID
11055955
Project number
75N91022C00010-P00009-9999-1
Recipient
IIT RESEARCH INSTITUTE
Principal Investigator
DAVID MCCORMICK
Activity code
N01
Funding institute
NIH
Fiscal year
2024
Award amount
$300,728
Award type
Project period
2022-04-01 → 2025-03-31